ArticleEuropean journal of breast health2023

Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention.

Fatma Nihan Akkoc Mustafayev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.